Hi folks, here are the top regulatory news stories to follow this week: GlaxoSmithKline has won U.S. approval for a new and improved shingles vaccine, Shingrix: https://www.reuters.com/article/us-usa-fda-gsk/gsk-wins-u-s-shingles-vaccine-approval-uk-nod-for-gene-therapy-idUSKBN1CS0TU The FDA expanded its approval for Alexion’s blood-disorder drug Soliris to include treatment for adults with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AchR) antibody-positive.  Soliris was[…]